Medicine

Permanent URI for this communityhttp://repository.kln.ac.lk/handle/123456789/12

This repository contains the published and unpublished research of the Faculty of Medicine by the staff members of the faculty

Browse

Has files: NoSubject: search.filters.subject.Albendazole

Search Results

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Effect of mass chemotherapy for filariasis control on soil-transmitted helminth infection in Western Province of Sri Lanka
    (The Royal Society of Tropical Medicine and Hygiene, 2007) Gunawardena, N.K.; Amarasekera, N.D.D.M.; Pathmeswaran, A.; de Silva, N.R.
    In July 2006, Sri Lanka completed five rounds of annual mass drug administration (MDA) with diethylcarbamazine citrate and albendazole as part of its national programme for elimination of lymphatic filariasis. Albendazole is also highly effective against soil-transmitted helminths (STH). This study was carried out to assess the impact of repeated annual MDA on STH infections in the Western Province of Sri Lanka, an area that is co-endemic for lymphatic filariasis and STH. A total of 17 schools in the Western Province were selected because they were included in a national survey of the health of school children in Grade 5 in 2003, when one round of MDA had been completed. Faecal samples were obtained again in 2006 (after five rounds of MDA), from one randomly selected class of Grade 5 students in the same schools. In both surveys, faecal samples were examined using the modified Kato-Katz technique. The prevalence and intensity of roundworm, whipworm and hookworm infections in 2003 and 2006 were compared using chi-square or Z-test for a difference between two percentages. Faecal samples from 255 children were examined in 2003; 448 were examined in 2006. Roundworm prevalence was marginally lower in 2006 (4.0%) than in 2003 (4.7%), as was hookworm (0.2% vs 0.4%) whereas whipworm prevalence was higher (13.8% vs 9.4%). Mean egg counts for all three infections were marginally higher in 2006. However, none of these differences were statistically significant. Compliance with MDA in 2006, as reported by the school children examined, was only 59%. These results indicate that four annual roundsof MDA with diethylcarbamazine and citrate and albendazole had virtually no impact on STH infections in the study area. It is likely that inclusion of of albendazole in MDA for lymphatic filariasis does not have much impact on STH infections in areas of low endemicity, unless very high coverage rates are achieved.
  • No Thumbnail Available
    Item
    Impact of mass chemotherapy for the control of filariasis on geohelminth infections in Sri Lanka
    (Academic Press, 2003) de Silva, N.R.; Pathmeswaran, A.; Fernando, S.D.; Weerasinghe, C.R.; Selvaratnam, R.R.; Padmasiri, E.A.; Montresor, A.
    No Abstract Available
  • No Thumbnail Available
    Item
    Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis
    (Oxford University Press, 1998) Ismail, M.M.; Jayakody, R.L.; Weil, G.J.; Nirmalan, N.; Jayasinghe, K.S.A.; Abeyewickreme, W.; Sheriff, M.M.R.; Rajaratnam, H.N.; Amarasekera, N.; de Silva, D.C.; Michalski, M.L.; Dissanaike, A.S.
    In a 'blind' trial on 50 male asymptomatic microfilaraemic subjects with Wuchereria bancrofti infection, the safety, tolerability and filaricidal efficacy of a single dose of albendazole (alb) 600 mg alone or in combination with ivermectin (iver) 400 microg/kg or diethylcarbamazine citrate (DEC) 6 mg/kg was compared with a single dose of the combination DEC 6 mg/kg and iver 400 micro g/kg over a period of 15 months after treatment. All but one subject, with 67 micro filariae (mf)/mL, had pre-treatment counts 100 mf/mL. All 4 treatments significantly reduced mf counts, but alb/iver was the most effective regimen for clearing mf from night blood: 9 of 13 subjects (69 percent) were amicro filaraemic by membrane filtration 15 months after treatment compared to one of 12 (8 percent), 3 of 11 (27 percent), and 3 of 10 (30 percent) in the groups treated with alb, alb/DEC, and DEC/iver, respectively. Filarial antigen tests suggested that all 4 treatments had significant activity against adult W. bancrofti; alb/DEC had the greatest activity according to this test, with antigen levels decreasing by 77percent 15 months after therapy. All 4 regimens were well tolerated and clinically safe, although mild, self-limited systemic reactions were observed in all treatment groups. These results suggest that alb/iver is a safe and effective single dose regimen for suppression of micro filaraemia in bancroftian filariasis that could be considered for control programmes. Additional benefits of this combination are its potent, broad spectrum activity against intestinal helminths and potential relative safety in areas of Africa where DEC cannot be used for filariasis control because of co-endemicity with onchocerciasis or loiasis
All items in this Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated. No item in the repository may be reproduced for commercial or resale purposes.